Multidisciplinary Association for Psychedelic Studies

Ecstasy for the Terminally Ill? Will This Party Drug Prove Effective Against Anxiety?

Medicine & Technology May 28, 2015

Scientists from the Multidisciplinary Association for Psychedelic Studies (MAPS) are hoping to help 18 terminally ill patients relieve their anxiety, depression, and fear in the next year during extended psychotherapy sessions enhanced by MDMA (ecstasy). The Marin County-based double-blind trial will see subjects test either full doses of MDMA (125 milligrams) or active placebo doses (30 milligrams).

Multidisciplinary Association for Psychedelic Studies

Ecstasy for the Terminally Ill? Will This Party Drug Prove Effective Against Anxiety?

Most Popular

Plato’s Long-Lost Grave Found Using AI To Decipher Herculaneum Scrolls; Greek Philosopher Had Been Sold Into Slavery: Report

Influenza Shows Highest 'Pandemic Potential' Among Ranked Pathogens, Study Reveals

Fastest Things in the Universe: Top 5 Cosmic Phenomena With Immensely High Speed

UFOs Piloted by Spiritual Entities? Fox News' Tucker Carlson Makes Bizarre Claim, Suggests That They Do Not Behave According to Laws of Science

Why Blue-Green Roofs Are Better Than Green? Is the Technology Applicable to Every Building?

Recommended Stories

Small Dark Formations on the Red Planet's Surface Appear Like Spider in Photos Captured by ESA's Mars Express

Citizen Scientists Identify New Sample of Over 1,000 Hidden Asteroids in Hubble’s Archival Data

NASA Engineers Successfully Repair Voyager 1 After 5 Months of Troubleshooting 15 Billion Miles Away

NASA Releases Stunning Concept Art of Lake Lava Loki Patera on Jupiter's Io Moon